Conversely, exosomes from the tumor microenvironment, such as cancer-associated fibroblasts (CAFs), deliver metabolic enzymes (e.g., PKM2) and anti-apoptotic miRNAs (e.g., miR-155) to CSCs, enhancing glycolysis and suppressing chemotherapy-induced cell death. The gene discussed is PKM; the disease is neoplasm.